Tag Archives: SVA

Hot Blue Chip Stocks To Invest In 2018

Many analysts have voiced fears that the U.S. stock markets march higher is overdone.

One chart watcher, on the other hand, is suggesting the opposite.

The breakout could be just getting started, wrote Jonathan Krinsky, chief market technician at MKM Partners, in a note dated Sunday.

This view comes after Krinsky looked not at the S&P 500
SPX, +0.39%
or the Dows
DJIA, +0.36%
30 blue chips, but rather at the Value Line Geometric Index
VALUG, +0.35%
, which consists of about 1,675 U.S. stocks.

Hot Blue Chip Stocks To Invest In 2018: Arc Wireless Solutions Inc.(ARCW)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested small cap manufacturing and 3D printing service provider ARC Group WorldWide (NASDAQ: ARCW) as a short trade:

Hot Blue Chip Stocks To Invest In 2018: Lincoln National Corporation(LNC)

Advisors’ Opinion:

  • [By Lee Jackson]

    Lincoln National Corp. (NYSE: LNC) also had the man at the top selling stock last week. Dennis Glass, the CEO of this insurance and retirement focused company, sold a block of 75,000 shares at between $71.00 and $71.28 apiece. The total for the sale was posted at $5 million. Shares closed Friday at $71.69, in a 52-week rangeof $34.16 to $73.71. The consensus price target is $73.17.

  • [By WWW.THESTREET.COM]

    * The market bent yesterday but today it stabilized. (A good showing, all things being considered–but in no way decisive going forward).
    * Gold +$5/oz.
    * Crude oil +$0.50 and the rise is taking up some energy stocks.
    * The Russell returned to the spotlight.
    * Life insurance–particularly Lincoln National (LNC) (on an upgrade). Hartford Financial Services (HIG) gets a small lift.
    * Retail returned from the depths. The standouts–L Brands (LB) , Kohl’s (KSS) , Bed Bath (BBBY) , Nordstrom (JWN) and Gap (GPS) .
    * Ag equipment–after an analyst upgrade yesterday.
    * Brokerages.
    * Homebuilders catch a bid.
    * Day one of the Masters Golf Tournament.

Hot Blue Chip Stocks To Invest In 2018: Ishares Trust Dj Us Financial (IYF)

Advisors’ Opinion:

  • [By Wayne Duggan]

    Investors looking to set up a pair trade to capitalize on the divergent paths of U.S. and European banks should consider going long the iShares Dow Jones US Financial (ETF) (NYSE: IYF) and short the Ishares MSCI Europe Fincls Sctr Indx Fd (NASDAQ: EUFN).

Hot Blue Chip Stocks To Invest In 2018: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

Hot Blue Chip Stocks To Invest In 2018: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares shot up 53 percent to $114.87 after the company impressed investors with encouraging data from a phase 3 clinical trial. Alnylam, a company dedicated towards treating a wide range of debilitating diseases through ribonucleic acid (RNA) interference (RNAi) therapeutics, said after Tuesday's market close that a phase 3 study called APOLLO met its primary efficacy endpoint and all secondary endpoints.

  • [By Cory Renauer]

    Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.

  • [By Chris Dier-Scalise]

    On Thursday, the Vetr crowd downgraded Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) from 4.5 stars (Strong Buy), which was issued two days ago, to 3.5 stars (Hold). Crowd sentiment for Alnylam at the time of the downgrade was edging positive, with 66 percent of Vetr user rating bullish.

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) jumped as much as 14.5% today after announcing earnings after the bell yesterday. As a development-stage biotech, it wasn’t the revenue or the earnings that caused the spike, but the progression of Allnylam’s pipeline.

  • [By Ben Levisohn]

    Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.

Hot Blue Chip Stocks To Invest In 2018: Vanguard Mega Cap Growth ETF (MGK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Three of Vanguard's mega-cap equity ETFs now sport annual expense ratios of 0.07 percent, down from 0.09 percent. Those ETFs are the Vanguard Mega Cap ETF (NYSE: MGC), Vanguard Mega Cap 300 Growth Index ETF (NYSE: MGK) and the Vanguard Mega Cap Value Index ETF (NYSE: MGV).

Top 10 Heal Care Stocks To Buy For 2018

MannKind (MNKD) investors saw Afrezza script sales close out November with an expected recovery from the week prior which was a holiday week. For the week ending December 1st, total Afrezza sales were just over 470 scripts. This number is at the high end of my script projection model. Afrezza sales have spent the bulk of Q4 in the 400 to 500 range vs. the 300 to 400 range that was seen in Q3. Sales are growing in line with my projections, but well below what is needed to impress the street.

Chart Source – Spencer Osborne

The quarter-over-quarter numbers in terms of scripts are showing a Q4 improvement of 19.02% increase over Q3. This is growth, but slower growth than needed. The silver lining is that with new SKUs, each script contains more cartridges and thus more dollars. This dynamic creates a bump in the revenue line. That bump is nice to see, but will not continue to outpace the script growth percentage for very long. Once the channel is filled with the new SKUs, the revenue percentage gains will more closely mirror the percentages we see in scripts. In other words, the average revenue per script will level off in the weeks ahead.

Top 10 Heal Care Stocks To Buy For 2018: Alphabet Inc.(GOOGL)

Advisors’ Opinion:

  • [By Lee Jackson]

    Alphabet Inc. (NASDAQ: GOOGL) had the man at the top of the search giant selling shares this past week. Lawrence Page shed two blocks of 33,332 shares. The first block was priced at $802.65 a share and the second one at $804.92. The total for the combined trades was a huge $53,583,423. The consensus price target for the stock is $966.68. The shares were changing hands on Friday’s close at $807.80.

  • [By Vikram Nagarkar]

    This Bloomberg reportis just one of the many recent reports which suggest that advertisers could take their ad Dollars elsewhere, or bargain hard to bring down ad prices on Facebook. With advertisers growing more wary of Facebook, it won’t come as a surprise ifAlphabet Inc’s (NSDQ:GOOGL)Google, with its massive reach and scale, emerges as a natural alternative for advertisers.However, a deeper look suggests that even Google might not have as much of a squeaky clean image as many believe it does. Quoting from the same Bloomberg post:

  • [By Virendra Singh Chauhan]

    Apple stock is currently trading at a PE multiple of 14.09, in line with the valuation multiples of other hardware companies like HP Inc (NYSE:HPQ) and Qualcomm (NSDQ:QCOM). However, the Apple services segment is significantly different from a ‘hardware’ business, whether in terms of operations or associated cost structure. It would, therefore, be more accurate to evaluate the segment as a services business in order to gauge its ‘value.’ Two popular companies which generate a ton of services revenue are Alphabet (NSDQ:GOOGL) and Facebook (NSDQ:FB).

  • [By Arie Goren]

    Recently, both suppliers of graphics processing units (GPUs) NVIDIA Corporation (NSDQ:NVDA)and Advanced Micro Devices, Inc. (NSDQ:AMD)have signed new collaborations with leading cloud companies to supply their GPUs to accelerate artificial intelligence in the enterprise. NVIDIA has announced a collaboration with tech giants Microsoft Corporation (NSDQ:MSFT)and International Business Machines (NYSE:IBM), while AMD received orders from Alphabet (NSDQ:GOOGL)to supply GPUs for Google cloud platform. Investors might wonder which one of the two companies NVIDIA or AMD is going to win the GPU race to become the primary supplier for artificial intelligence uses. While right now Nvidia dominates the GPU application in AI, in my opinion, there is enough room for both companies to grow in this marker significantly. Therefore, as I see it, to take advantage of the fast-growing deep learning and artificial intelligence market, it is better to invest in shares of both companies.

  • [By The Ticker Tape]

    Last week ended with a string of results from some of the biggest companies in the tech sector. Positive results continued with earnings beats from Amazon.com, Inc. (NASDAQ: AMZN), Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL), and Microsoft Corporation (NASDAQ: MSFT). AMZN and GOOG also beat revenue estimates, but MSFT came up shy of Wall Street’s top-line estimates. Tech earnings continue this week with Apple Inc. (NASDAQ: AAPL) reporting fiscal Q2 results after market close tomorrow. 

Top 10 Heal Care Stocks To Buy For 2018: (LVMUY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    (Incidentally, the operating structure and history of growth through smart acquisitions and management is a reminiscent story behind the rise of Bernard Arnault and The Arnault Family Group, which is the majority controlling shareholder in LVMH Mo毛t Hennessy Louis Vuitton S.E. (OTCPK:LVMUY) and Christian Dior SE in the ultra-luxury goods industry.)

Top 10 Heal Care Stocks To Buy For 2018: Transcananda Pipelines Ltd.(TRP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    After a series of setbacks in its attempts to build new oil pipelines, Canadian pipeline giant TransCanada (NYSE:TRP) completed a transformation transaction to acquire U.S. natural gas pipeline company Columbia Pipeline Group for $13 billion, which includes the assumption of debt. The key to that deal was that it increased the combined company’s near-term project pipeline to 23 billion Canadian dollars, which supports TransCanada’s ability to increase its dividend by 8% to 10% annually through 2020. After completing that deal, TransCanada made a bid to acquire all of the outstanding units that it did not own of affiliated MLP Columbia Pipeline Partners (NYSE:CPPL) in a transaction valued at $915 million. These acquisitions solidified TransCanada’s natural gas pipeline growth ambitions, enabling it to diversify away from oil pipelines.

  • [By Paul Ausick]

    That includes pipeline companies like Kinder Morgan Inc. (NYSE: KMI), which already operates a pipeline transporting natural gas from Texas into Mexico, and master limited partnerships (MLPs) Energy Transfer Partners L.P. (NYSE: ETP) and TransCanada Corp. (NYSE: TRP), the company that has (so far) failed to get U.S. approval for its Keystone Pipeline expansion from Canada’s oil sands across the U.S. border.

  • [By WWW.KIPLINGER.COM]

    Energy stocks were driven by a hefty dose of M&A during the third quarter. And that will drive returns for TransCanada Corporation (TRP) during the next one.

  • [By Ben Levisohn]

    In a number of articles recently, following the US recent revival and potential approval of the previously blocked Keystone XL pipeline, a number of estimates have been provided suggesting a pending boom for the US steel industry is on the horizon (and US steel stocks have reacted in kind). In fact, this optimism, we believe, peaked today when a report from one of our competitors was published claiming that, the keystone XL pipeline could increase line pipe demand by 14.7% for 2 years. The problem here, we believe, rests with the facts that: (a) TransCanada (TRP) has already taken, and paid for, the steel to build the Keystone XL pipeline (the steel currently sits in storage facilities in both Regina, Canada and Arkansas, United States), (b) neither US Steel (X; SELL), AK Steel, Steel Dynamics, or Nucor have the ability to make the specialized steel required for the miles of pipe associated with this project, to include both the thickness and pressure requirements, according to this article from Reuters, and (c) assuming some of the pipe does need replacement, this would likely come from international steel makers who are capable of producing the specialized steel (again, as highlighted in this Reuters article).

Top 10 Heal Care Stocks To Buy For 2018: TiVo Inc.(TIVO)

Advisors’ Opinion:

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 21 percent to $9.30. The New York Times, citing sources familiar with the issue, said Rovi Corporation (NASDAQ: ROVI) is in advanced negotiations to acquire TiVo. TiVo shareholders would reportedly receive both cash and stock; however, the price tag is yet to be determined.

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 20 percent to $9.22. The New York Times reported that Tivo and Rovi Corporation (NASDAQ: ROVI) are in merger talks.

Top 10 Heal Care Stocks To Buy For 2018: MGM Resorts International(MGM)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    MGM Resorts International (NYSE: MGM) is also a top pick for the first quarter, and Merrill Lynch’s price objective of $33.00 was versus a recent price of $28.50. The consensus analyst target price is a tad higher at $33.86.

  • [By JJ Kinahan]

    The earnings parade continues as the Fed wraps up its July meeting. Biotech giant Gilead Sciences, Inc. (NASDAQ: GILD) reports today after market close, and tomorrow morning both Verizon Communications Inc. (NYSE: VZ) and MGM Resorts International (NYSE: MGM) release their second-quarter results.  

  • [By Wayne Duggan]

    According to Deutsche Bank analyst Carlo Santarelli, news that Las Vegas Sands Corp. (NYSE: LVS) may be selling its Sands Bethlehem resort to MGM Resorts International (NYSE: MGM) could be a win-win-win for Sands, MGM and MGM Growth Properties LLC (NYSE: MGP).

Top 10 Heal Care Stocks To Buy For 2018: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Agenus (NASDAQ: AGEN) rose 22.99% to $3.37 after the company reported positive follow-on Phase 2 results for brain cancer vaccine.

    Aeropostale (NYSE: ARO) shares jumped 18.23% to $10.18 after private equity firm Sycamore Partners bought a 7.96% stake in the company.

  • [By Cory Renauer]

    Shares of Agenus Inc (NASDAQ:AGEN), a biopharmaceutical company developing cancer therapies, had fallen about 14.5% as of 3:20 p.m. EST on Wednesday. Investors weren’t too thrilled about its cancer vaccine’s recent clinical trial failure.

Top 10 Heal Care Stocks To Buy For 2018: MEI Pharma, Inc.(MEIP)

Advisors’ Opinion:

  • [By Chris Lange]

    MEI Pharma, Inc. (NASDAQ: MEIP) saw its shares make a solid gain on Thursday after the company received a crucial upgrade from Oppenheimer. Most analysts only issue price targets that are within a range of 5% to 25% for stocks, but this upgrade absolutely blows these small calls out of the water.

Top 10 Heal Care Stocks To Buy For 2018: BiondVax Pharmaceuticals Ltd.(BVXV)

Advisors’ Opinion:

  • [By Chris Lange]

    BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) reported that the scientific journal “Vaccine” published an article citing results from its flu vaccine. The “Vaccine” article, Back to the future: Immunization with M-001, reports that blood plasma samples from people who received M-001 in 2011 (as part of BiondVax’s BVX-005 clinical trial in the elderly) showed significantly increased protective antibodies against the new epidemic 2014/15 flu strain (A/Swiss) – a strain which did not exist when M-001 was administered to the BVX-005 participants.

Top 10 Heal Care Stocks To Buy For 2018: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

Top 10 Heal Care Stocks To Buy For 2018: New York & Company Inc.(NWY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of New York & Company, Inc. (NYSE: NWY) got a boost, shooting up 13 percent to $2.31 as the company posted upbeat quarterly results.

    The GEO Group Inc (NYSE: GEO) shares were also up, gaining 19 percent to $23.27. Following Thursday’s Department of Justice news regarding privately-managed prisons, GEO Group dropped on Thursday, but rebounded Friday after issuing a response to the DoJ.

  • [By Monica Gerson]

    New York & Company, Inc. (NYSE: NWY) shares dropped 42 percent to $1.72 after the company reported downbeat Q1 results and issued a weak Q2 forecast.

stock shares

Small cap Canada focused gold exploration and developmentstockAlexandria Minerals Corp (OTCQB: ALXDF; TSE: AZX.V)has just begun a 30,000 metre drilling program at its Orenada Zone 4 gold project in Val dOr, Quebec. Alexandria Minerals Corp issearching for gold much closer to homefor many investors as the Company has aportfolio ofstrategic properties located in the world-class mining districts of Val dOr, Quebec; Red Lake, Ontario; and Snow Lake-Flin Flon, Manitoba:

Last year, Alexandria Minerals Corp completed an Option/Joint Venture on three of its projects (in Matachewan, Ontario; Chibougamau, Quebec; and eastern Val dOr)to enable the Company to focus on its flagshipwestern Cadillac Break Properties in the Val dOr. Cadillac Break is amajor regional fault zone where mines have produced some 100 million ounces of gold over the past 90 years while the Companys properties themselves have been explored by various operators since the early 1930s with over 2,400 drill holes completed since that time.

stock shares: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

stock shares: Triple-S Management Corporation(GTS)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap Triple-S Management Corp (NYSE: GTS) is an independent licensee of the Blue Cross Blue Shield Association. It is one of the leading players in the managed care industry in Puerto Rico. Triple-S Management has the exclusive right to use the Blue Cross Blue Shield name and mark throughout Puerto Rico, the U.S. Virgin Islands, and Costa Rica. With more than 50 years of experience in the industry, Triple-S Management offers a broad portfolio of managed care and related products in the Commercial, Medicare Advantage, and Medicaid markets under the Blue Cross Blue Shield marks. It also provides non-Blue Cross Blue Shield branded life and property and casualty insurance in Puerto Rico.

stock shares: Phillips 66 Partners LP(PSXP)

Advisors’ Opinion:

  • [By Dustin Parrett]

    In 2016, PAA partnered with Phillips 66 Partners LP (NYSE: PSXP) to build a $15 million pipeline expansion between Oklahoma and Canada. The new pipeline adds capacity for 100,000 more barrels of oil a day.

  • [By Matthew DiLallo]

    The other highlight this quarter was the midstream business. That segment benefited from a full quarter of Phillips 66’s recently completed Freeport LPG Export Terminal as well as a turnaround in results at DCP Midstream (NYSE:DCP). After causing the company to record a loss on its investment last quarter, the DCP Midstream investment was back in the green this quarter, benefiting from hedging and lower costs. Meanwhile, the company’s other MLP investment, Phillips 66 Partners (NYSE:PSXP), delivered another steady quarter thanks to that entity’s focus on owning stable fee-based assets.

  • [By Jon C. Ogg]

    Phillips 66 Partners (NYSE: PSXP) was raised to Buy from Neutral with a $60 price target at Goldman Sachs on December 18. The units were last seen trading at $51.23, and the 5% yield would represent a total return of over 22% if the firm is correct. The 52-week range is $44.40 to $58.00, and the consensus price target is $59.43.

stock shares: Immersion Corporation(IMMR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Immersion Corporation (NASDAQ: IMMR) shares were also up, gaining 20 percent to $7.18. Immersion disclosed that Vic Viegas has agreed to resign as CEO and as a director. The company named Carl Schlachte as Interim CEO.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Movers newsletter suggested shorting small cap technology stock Immersion Corporation (NASDAQ: IMMR):

    We love how well developed the selling of Immersion shares has been. Rather than a sharp, v-shaped reversal — which may or may not follow through — we’ve seen a bowl-shaped transition from an uptrend to a downtrend. This ups the odds of downside follow-through, as there’s been no price “shock” to invite a sudden wave of buying.

  • [By Lisa Levin]

    Immersion Corporation (NASDAQ: IMMR) shares were also up, gaining 22 percent to $7.29. Immersion disclosed that Vic Viegas has agreed to resign as CEO and as a director. The company named Carl Schlachte as Interim CEO.

Hot Blue Chip Stocks To Buy Right Now

Retirement investing is not what it used to be. In the old days, one could just invest in the safe stocks to buy, in blue chips, in a nice ladder of bonds, and do just fine.

Alas, the market has significantly changed. Much of this is due to the historically low interest rates weve had.

The problem with the Federal Reserves attempt to goose the economy is that it killed bond yields, forcing retired investors further out onto the risk curve, making it difficult to find safe stocks to buy. That has pushed stock prices far higher than they should be, if one subscribes (as I do) to the Peter Lynch theory that a stocks price should reflect its net income growth rate to be added to a list of stocks to buy.

Hot Blue Chip Stocks To Buy Right Now: StarTek, Inc.(SRT)

Advisors’ Opinion:

  • [By Jim Robertson]

    Just before Thanksgiving, our Under the Radar Moversnewsletter suggested shortingsmall cap business process outsourcing (BPO) stock StarTek, Inc (NYSE: SRT):

Hot Blue Chip Stocks To Buy Right Now: Neuralstem, Inc.(CUR)

Advisors’ Opinion:

  • [By William Romov]

    Last Wednesday (Dec. 6), the company received a patent for certain methods of production of its phase 2 antidepressant, AV-101.

    Penny Stock Current Share Price Dec. 4 – Dec. 8 Gain (as of Dec. 8)
    VistaGen Therapeutics Inc. (Nasdaq: VTGN) $1.80 135%
    FXCM Inc. (Nasdaq: GLBR) $1.12 124%
    Neuralstem Inc. (Nasdaq: CUR) $2.00 75.44%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.49 75.29%
    ClearSign Combustion Corp. (Nasdaq: CLIR) $3.50 53.85%
    Astrotech Corp. (Nasdaq: ASTC) $4.21 51.99%
    Burcon NutraScience Corp. (Nasdaq: BUR) $0.72 44%
    LM Funding America Inc. (Nasdaq: LMFA) $3.72 42.53%
    Second Sight Medical Products Inc. (Nasdaq: EYES) $1.75 42.28%
    Globus Maritime Ltd. (Nasdaq: GLBS) $1.47 41.35%

    As a result, its share price shot up from $0.92 to $2.52 on Wednesday. The stock pulled back to $1.80 by the end of the week, for a total gain of 135% for the week.

  • [By Lisa Levin]

    Shares of Neuralstem, Inc. (NYSE: CUR) were down 29 percent to $1.75. Neuralstem reported the pricing of public offering of common stock and warrants.

Hot Blue Chip Stocks To Buy Right Now: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

how to invest money

First Trust Cloud Computing ETF (NASDAQ:SKYY) is the first and only ETF to provide exposure to the fast-growing cloud computing industry. This market segment is growing by leaps and bounds and should do so for several years to come. For example, Amazon (NASDAQ:AMZN) Web Services recently announced that its operating income increased from $580 million in the year-ago quarter to $926 million in the fourth quarter of 2016. Meanwhile, Microsoft (NASDAQ:MSFT) announced that Azure revenue surged 93% year-over-year.

According to research firm IDC:

Between now and 2020, worldwide spending on public cloud services is expected to soar to more than $195 billion. This is double the revenue the industry is expected to generate by the end of 2016.

The share price of SKYY should be in the clouds, right?

Well, no. Despite the great promise for cloud computing, the ETF has not really performed much better than the S&P 500.

how to invest money: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    The biotechs and emerging pharma havebeen under pressure from politicians attacking drug prices. That doesn’t mean that there are not some big winners out there. Sometimes the biggest winners are companies most investors have never heard of. Even if you have been a biotech and emerging pharma investor for years, chances are high that you would have never heard of a small outfit called Apricus Biosciences Inc. (NASDAQ: APRI).

how to invest money: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

how to invest money: Modine Manufacturing Company(MOD)

Advisors’ Opinion:

  • [By Monica Gerson]

    Modine Manufacturing Co. (NYSE: MOD) is projected to post its quarterly earnings at $0.32 per share on revenue of $351.33 million.

    Navios Maritime Holdings Inc. (NYSE: NM) is expected to report a quarterly loss at $0.37 per share on revenue of $101.51 million.

how to invest money: Werner Enterprises, Inc.(WERN)

Advisors’ Opinion:

  • [By Monica Gerson]

    Werner Enterprises (NASDAQ: WERN) shares dropped 4.83% to $23.23 in pre-market trading after the company issued a weak third-quarter profit forecast.

  • [By Monica Gerson]

    Werner Enterprises (NASDAQ: WERN) issued a weak third-quarter profit forecast. Werner shares dropped 2.09% to $23.90 in the after-hours trading session.

  • [By Michael Flannelly]

    Following Werner Enterprises, Inc.’s (WERN) third quarter earnings warning, analysts at KeyBanc downgraded the transportation and logistics company on Tuesday.

    The analysts downgraded WERN from “Buy” to “Hold.”

    KeyBanc analyst Todd Fowler said, “We downgrade WERN from Buy to HOLD following its negative 3Q pre-ann’ct, which reflected a number of company-specific issues that we expect to limit upside going forward; we would focus investors on other, stronger-performing names within the truckload space, specifically, BUY-rated Swift Transportation Company (SWFT), Marten Transport Ltd. (MRTN), and Knight Transportation Inc. (KNX).”

    Werner Enterprises shares were down $1.66, or 6.80%, during pre-market trading on Tuesday. The stock is up 12.64% year-to-date.

  • [By Jake L’Ecuyer]

    Equities Trading DOWN
    Shares of Outerwall (NASDAQ: OUTR) were down 16.03 percent to $47.00 after the company lowered its forecast for the third quarter and full year. Werner Enterprises (NASDAQ: WERN) shares tumbled 4.71 percent to $23.26 after the company issued a weak third-quarter profit forecast. Bank of America downgraded the stock from Buy to Neutral. Pandora Media (NYSE: P) down, falling 1.71 percent to $23.58 as the company announced its plans to sell 14 million shares of common stock, including 4 million shares from current stockholders.

how to invest money: C.H. Robinson Worldwide, Inc.(CHRW)

Advisors’ Opinion:

  • [By Chad Tracy]

    As it's known today, C.H. Robinson (Nasdaq: CHRW) has again changed with the times.

    Unlike transportation industry titans FedEx (NYSE: FDX) or UPS (NYSE: UPS), C.H. Robinson does not own a fleet of trucks that transport goods. Instead, it specializes in logistics. Other companies hire C.H. Robinson to make their transportation services more efficient.

  • [By Gary Jakacky]

    Only one company convincingly jumped thru all the hoops: C.H. Robinson Worldwide, Inc. (CHRW).

    If only one of the companies in IYT appear to be undervalued, it might give you pause about how brightly the ETF will shine in the very near future.

  • [By Lisa Levin]

    Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) were down 4 percent to $71.69. UBS downgraded C.H. Robinson Worldwide from Neutral to Sell.

how to invest money: OncoSec Medical Incorporated(ONCS)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo